Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infectionPeter D McElroy, Kashef Ijaz, Lauren A Lambert, et al.Plos One|November 5, 2015
Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012Roque Miramontes, Andrew N Hill, Rachel S Yelk Woodruff, et al.Epidemiology (Cambridge, Mass.)|November 26, 2019
Robustness of NHANES Estimates of the US Prevalence of a Positive Tuberculin Skin TestMaryam B Haddad, Timothy L Lash, Andrew N Hill, et al.American Journal of Preventive Medicine|February 17, 2020
Tuberculosis Infection Among People With Diabetes: United States Population Differences by Race/EthnicityMaryam B Haddad, Timothy L Lash, Kenneth G Castro, et al.Plos One|March 9, 2013
Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreakMidori Kato-Maeda, Christine Ho, Ben Passarelli, et al.Proceedings of the National Academy of Sciences of the United States of America|February 16, 2006
Variable host-pathogen compatibility in Mycobacterium tuberculosisSebastien Gagneux, Kathryn DeRiemer, Tran Van, et al.The Journal of Infectious Diseases|August 30, 2007
HIV infection and multidrug-resistant tuberculosis: the perfect stormCharles D Wells, J Peter Cegielski, Lisa J Nelson, et al.American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic servicesJlucian Davis, Achilles Katamba, Josh Vasquez, et al.Emerging Infectious Diseases|October 25, 2012
Challenges and controversies in defining totally drug-resistant tuberculosisPeter Cegielski, Paul Nunn, Ekaterina V Kurbatova, et al.Open Forum Infectious Diseases|February 2, 2022
Association of Tumor Necrosis Factor α Inhibitor Use with Diagnostic Features and Mortality of Tuberculosis in the United States, 2010-2017Shereen S Katrak, Rongxia Li, Sue Reynolds, et al.Pageof 11